AKASA builds custom LLMs for health systems to automate revenue cycle workflows—prior authorization, clinical documentation improvement, inpatient coding, and denials appeals. The stack is data-heavy (Kubernetes, dbt, Redshift, PostgreSQL, Prefect) with Llama and Claude at the core, revealing a company operating at the intersection of healthcare data pipelines and large-language-model deployment. The hiring mix is engineering-dominant with significant data infrastructure investment, reflecting the complexity of building production ML systems that must integrate with clinical workflows and regulatory constraints.
AKASA provides generative AI solutions tailored to healthcare revenue cycle management for large health systems. Founded in 2019 and headquartered in South San Francisco, the company deploys custom language models to capture clinical nuance and improve accuracy across mid-cycle revenue functions. The product surface spans prior authorization, clinical documentation improvement, inpatient coding, and clinical denials appeals. Projects center on dbt-based data platform infrastructure, clinical documentation and coding automation, in-app dashboarding, and CI/CD pipeline maturity. The company operates across the United States and Venezuela, with steady hiring velocity concentrated in engineering and data roles.
Kubernetes, Terraform, GitHub, SQL, dbt, Redshift, PostgreSQL, Python, Prefect, Grafana, AWS, and large-language models including Llama and Claude. They also integrate FHIR and HL7 healthcare data standards.
South San Francisco, California. The company is privately held with 51–200 employees and was founded in 2019.
Other companies in the same industry, closest in size